跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 33 条关于
“pandaOmics”
全部
33
临床试验
17
药物
0
机构
0
资讯
16
上个月
Insilico Medicine Uses AI to Map Molecular Landscape and Identify Therapeutic Targets for Rare Sinonasal Cancer
去年
Insilico Medicine Develops Novel AI-Designed CDK12/13 Inhibitors for Treatment-Resistant Cancers
4年前
Insilico Medicine's AI-Discovered Anti-fibrotic Drug Enters Phase I Clinical Trial for IPF
去年
AI-Designed Drug ISM001-055 Shows Promise in Phase IIa Trial for Idiopathic Pulmonary Fibrosis
去年
Insilico Medicine Develops AI-Designed ENPP1 Inhibitor ISM5939 for Cancer Immunotherapy
去年
AI-Discovered Drug INS018_055 Enters Phase 2 Trials for Idiopathic Pulmonary Fibrosis
9个月前
AI-Driven Study Identifies (Z)-Endoxifen as Promising Therapeutic Candidate for Glioblastoma
2年前
AI and Multi-Omics Drive Breakthrough Advances in Anti-Aging Drug Development
2年前
AI Revolutionizes Drug Discovery: Industry Leaders Share Latest Advances at London Conference
去年
AI-Discovered Drug Rentosertib Shows Promising Phase IIa Results for Idiopathic Pulmonary Fibrosis
第 1 页,共 2 页
上一页
下一页